High Net Worth Advisory Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Hold |
1,500
| – | – | 0.13% | 132 |
|
|
2025
Q1 | $405K | Hold |
1,500
| – | – | 0.11% | 140 |
|
|
2024
Q4 | $353K | Hold |
1,500
| – | – | 0.1% | 156 |
|
|
2024
Q3 | $413K | Hold |
1,500
| – | – | 0.11% | 143 |
|
|
2024
Q2 | $365K | Hold |
1,500
| – | – | 0.11% | 142 |
|
|
2024
Q1 | $224K | Hold |
1,500
| – | – | 0.07% | 194 |
|
|
2023
Q4 | $287K | Hold |
1,500
| – | – | 0.11% | 151 |
|
|
2023
Q3 | $266K | Hold |
1,500
| – | – | 0.11% | 149 |
|
|
2023
Q2 | $285K | Hold |
1,500
| – | – | 0.11% | 148 |
|
|
2023
Q1 | $300K | Hold |
1,500
| – | – | 0.12% | 145 |
|
|
2022
Q4 | $356K | Hold |
1,500
| – | – | 0.14% | 130 |
|
|
2022
Q3 | $300K | Hold |
1,500
| – | – | 0.13% | 139 |
|
|
2022
Q2 | $219K | Buy |
1,500
+500
| +50% | +$73K | 0.09% | 177 |
|
|
2022
Q1 | $163K | Hold |
1,000
| – | – | 0.06% | 205 |
|
|
2021
Q4 | $170K | Buy |
+1,000
| New | +$170K | 0.06% | 201 |
|